Clinical Trial Update: Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of RRx-001 to attenuate oral mucositis in patients receiving chemoradiation for oral cancer; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Cancer
• Oral Mucositis

Drugs mentioned

• RRx-001

Snippet

Sponsor: EpicentRx, Inc. | Conditions: Oral Mucositis | Phase 2 | Status: COMPLETED | Results posted: 2024-11-04